OBJECTIVE	Genetic polymorphism of interleukin ( IL ) -1 and IL-1 receptor antagonist ( IL-1r ) are associated with efficacy of acid suppression , whereas cytochrome P ( CYP ) 2C19 polymorphism influences the metabolism of proton pump inhibitor family .\